Novartis’ IL-17 inhibitor Cosentyx has become the first new biological therapy for the painful skin condition hidradenitis suppurativa (HS) in nearly a decade, following its approval by the European ...

Novartis' blockbuster immunology drug Cosentyx has disappointed in a phase 3 trial involving patients with giant cell arteritis (GCA), a debilitating autoimmune disease affecting the arteries. In the ...

Frisco, Texas — December 15, 2025 — PSBP Law is pleased to announce the opening of its… Goranson Bain Ausley (GBA), the largest family law firm in Texas, is expanding its Fort… Please join the Dallas ...

Showcase your company news with guaranteed exposure both in print and online Get ready for the annual Columbus Business First Power Breakfast… Where Ambition Finds Direction Join us as we celebrate ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of financial accounting, ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ...

Angelica Leicht is a seasoned personal finance writer and editor with nearly two decades of experience but just one goal: to help readers make the best decisions for their wallets. Her expertise spans ...

Invest in diverse CRE types, as sectors like industrial and retail show varying demand and yield. Research local markets extensively to avoid investing in oversupplied or declining sectors. Understand ...